Soy in hypercholesterolaemia: A double-blind, placebo-controlled trial

European Journal of Clinical Nutrition

Volumn 56, Issue 4, 2002, Pages 352-357

  Puska, P ^a   Korpelainen, V ^a   Hoie L H ^b   Skovlund, E ^c   Lahti, T ^d   Smerud, K T ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Nutri Pharma A/S   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

^d Smerud Medical Research International AS   (Norway)

Author keywords

Double blind; Hypercholesterolaemia; Placebo controlled; Soy

Indexed keywords

ABACOR; CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOYBEAN PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COTYLEDON; DATA BASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FINLAND; HEALTH CENTER; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

GLYCINE MAX;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FINLAND; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; SOYBEAN PROTEINS;

EID: 85047695861     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601340     Document Type: Article

References (22)

1. Epidemiology of phytoestrogens
2. Meta-analysis of the effects of soy protein intake on serum lipids
3. Effects of soy isoflavones on atherosclerosis: Potential mechanisms
4. Endocrinological responses to soy protein and fiber in mildly hypercholesterolemic men (25 g study)
5. Adverse drug reactions caused by statins, with emphasis on psychiatric reactions
6. A randomised trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
7. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
8. Functional foods
9. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice
10. Physiological effects of physico-chemical properties of soy cotyledon fiber
11. Soy protein and casein in cholesterol-enriched diets: Effects on plasma lipoproteins in normolipidemic subjects
12. Lipoprotein (a) and dietary proteins: Casein lowers lipoprotein (a) concentrations as compared with soy protein
13. Changes in diet in Finland from 1972 to 1992: Impact on coronary heart disease risk
14. Depression of plasma cholesterol in men by consumption of baked products containing soy protein
15. Soy proteins and cardiovascular disease: The impact of bioactive components in soy
16. Soy protein and isoflavones: Their effect on blood lipids and bone density in postmenopausal women
17. Reduction of serum cholesterol by soy proteins: Clinical experience and potential molecular mechanisms
18. US FDA Food labeling: Health claims; soy protein and coronary heart disease
19. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
20. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men